Aperture Venture Partners

Aperture Venture Partners is a venture capital group focused primarily on the healthcare and healthy living industries. Initial investment size ranges between $1 million and $5 million and they invest nationally.

Aperture invests in consumer goods, medical device, biopharmaceutical, biotechnology, healthcare information technology services and diagnostic sectors. The firm was founded in 2002 by Eric H. Sillman and Paul E. Tierney, Jr.

The firm works exclusively in the healthcare industry. Aperture's principals have been entrepreneurs in the healthcare and investment industries. They have invested more than $1 billion and founded companies that have had combined revenues greater than $2 billion.

Aperture Venture Partners has raised a total of $49.2M in a single venture fund, Aperture Venture Partners III, L.P. This fund was announced on Dec 31, 2014, and raised a total of $49.2M. The firm has made 34 investments, one of which was on Sep 14, 2018, when they invested $45M in ENDOTRONIX. Aperture Venture Partners has had 15 exits, the most notable ones including Avedro, Inspire Medical Systems, and Aclaris Therapeutics. The firm has $6.4M in revenue annually.

Aperture Venture Partners, LLC is a venture capital firm specializing in early-stage investments. It seeks to invest in the healthcare and healthy living industries. Within the healthcare industry, the firm invests in biopharmaceutical, biotechnology, healthcare services, healthcare information technology, diagnostics, drug discovery/delivery, and medical devices. Its investments in the healthy living category include companies that offer products or services in the areas of personal care; weight management; complementary and alternative medicines; vitamins, minerals, and supplements; beverages; sporting goods; apparel; retail; and travel. The firm seeks to invest in companies based in the West Coast and North Eastern United States. It typically invests between $1 million and $5 million in its portfolio companies. The firm seeks to be the lead investor and can also co-invest.